The role of complement anaphylatoxin C5a in neurodegeneration: Implications in Alzheimer's disease

Journal of Neuroimmunology

Volumn 105, Issue 2, 2000, Pages 124-130

  Mukherjee, Piali ^a   Pasinetti, Giulio Maria ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Anaphylatoxin; Apoptosis; Caspase; Inflammation

Indexed keywords

ANAPHYLATOXIN; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN);

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYME REGULATION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034717942     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00261-1     Document Type: Article

References (62)

1. 1A receptor causes suppression of anoxia-induced apoptosis via mitogen activated protein kinase in neuronal HN2-5 cells. J. Neurochem. 72:1999;1489-1496.
2. Aisen, P.S., Davis, K.L., Berg, J., Schafer, K., Campbell, K., Thomas, R., Weiner, M.F., Farlow, M.R., Sano, M., Grundman, M., Thals, L.J., 2000. A randomized controlled trial of predrisone in Alzheimer's Disease. Neurology, (in press).
3. Amatruda T.T., Gerard N., Gerard C., Simon M. Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268:1993;10139-10144.
4. Barria A., Muller D., Derkach V., Griffith L.S., Soderling T.R. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science. 276:1997;2042-2048.
5. Buhl A.M., Avdi N., Worthen G.S., Johnson G.L. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc. Natl. Acad. Sci. 91:1994;9190-9194.
6. Burgi B., Otten U.H., Ochensberger B., Rihs S., Heese K., Ehrhard P.B., Ibanez C.F., Dahinden C.A. Basophil priming by neurotrophic factors. J. Immunol. 157:1996;5582-5588.
7. Campos-Gonzalez R., Kindy M.S. Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain. J. Neurochem. 59:1992;1955-1958.
8. Cheng H., Rojas-Soto M., Oguni A., Kennedy M.B. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM Kinase II. Neuron. 20:1998;895-904.
9. Churn S.B., Limbrick D., Sombati S., DeLorenzo R.J. Excitotoxic activation of the NMDA receptor results in inhibition of calcium/calmodulin kinase ii activity in cultured hippocampal neurons. J. Neurosci. 15:1995;3200-3214.
10. Churn S.B., Taft W.C., Billingsley M.S., Sankaran B., DeLorenzo R.J. Global forebrain ischemia induces a posttranslational modification of multifunctional calcium-and calmodulin-dependent kinase II. J. Neurochem. 59:1992;1221-1232.
11. Churn S.B., Yaghmai A., Povlishock J., Rafiq A., DeLorenzo R.J. Global forebrain ischemia results in decreased immunoreactivity of calcium/calmodulin-dependent protein kinase II. J. Cerebral Blood Flow and Metab. 12:1992;784-793.
12. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
13. Du Y., Bales K.R., Dodel R.C., Hamilton-Byrd E., Horn J.W., Czilli D.L., Simmins L.K., Ni B., Paul S.M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. 94:1997;11657-11662.
14. Enselen H., Tokumistu H., Stork P.J., Davis R.J., Soderling T.R. Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase pathway. Proc. Natl. Acad. Sci. USA. 93:1996;10803-10808.
15. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., Okada H. A neuronal C5a receptor and an associated apoptotic signal transduction pathway. J. Physiol. 507.3:1998;679-687.
16. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., Morgan P. Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:1995;4882-4889.
17. Gass P., Kiessling M., Bading H. Regionally selective stimulation of mitogen activated protein (MAP) kinase tyrosine phosphorylation after generalized seizures in the rat brain. Neurosci. Lett. 162:1993;39-42.
18. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Science. 349:1991;614-617.
19. Hanson P.I., Schulman H. Neuronal Ca2+/calmodulin-dependent protein kinases. Annu. Rev. Biochem. 61:1992;559-601.
20. Hoepken U.E., Lu B., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defense to infection. Nature. 383:1996;86-89.
21. Hugli T.E. The structural basis for anaphylatoxin and chemotactic functions of C3A, C4a, and C5a. CRC Crit. Rev. Immunol. 1:1981;321-366.
22. Ilschner S., Nolte C., Kettenmann H. Complement factor C5A and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia. Neuroscience. 73:1996;1109-1120.
23. Jiang H., Burdick D., Glabe C.G., Cotman C.W., Tenner A.J. b-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J. Immun. 152:1994;5050-5059.
24. Kim T., Pettingell W.H., Jung Y., Kovacs D.M., Tanzi R.E. Alternative cleavage of Alzheimer's-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-376.
25. Konteatis Z.D., Siciliano S.J., Riper G.V., Molineaux C.J., Pandya S., Fischer P., Rosen H., Mumford R.A., Springer M.S. Development of C5a receptor antagonists, differential loss of functional responses. J. Immunol. 153:1994;4200-4205.
26. Kuida K., Zheng T.S., Na S., Kuan C.-Y., Yang D., Karasuyama H., Rakic P., Flavell R.A. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:1996;368-372.
27. Lampert-Etchells M., Pasinetti G.M., Finch C.E., Johnson S.A. Regional localization of cells containing C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration. 2:1993;111-121.
28. Lee A., Whyte M.K.B., Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukocyte Bio. 54:1993;283-288.
29. Leonard A.S., Lim I.A., Hemsworth D.E., Horne M.C., Hell J.W. Calcium/calmodulin-dependent protein kinase II is associated with N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA. 96:1999;3239-3244.
30. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemeri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
31. Lipton S.A., Rosenberg P.A. Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
32. Manjo G., Joris I. Apoptosis, oncosis and necrosis: an overview of cell death. Am. J. Pathol. 146:1995;3-15.
33. Michaelis M.L., Ranciat N., Chen Y., Bechtel M., Ragan R., Hepperle M., Liu Y., Georg G. Protection against β-ameloid toxicity in primary neurons by paclitaxel (Taxol). J. Neurochem. 70:1998;1623-1627.
34. 2+ signaling in mouse microglia. J. Neurosci. 17:1997;615-624.
35. Monk P., Bank P. The role of protein kinase C activation and inositol phosphate production in the regulation of cell-surface expression of MAC-1 by complement fragment C5a. Biochim. Biophys. Acta. 1092:1991;251-255.
36. Natsaf S., Stahel P.F., Davoust N., Barnum S.R. Complement anaphylatoxin receptors on neurons: new tricks for old receptors. Trends Neurosci. 22:1999;397-402.
37. Nolte C., Möller T., Walter T., Kettenmann H. Complement 5a controls motility of murine microglial cells in vitro via activation of an inhibitory G-protein and the rearrangement of the actin cytoskeleton. Neuroscience. 73:1996;1091-1107.
38. Oda T., Lehrer-Graiwer J., Finch C.E., Pasinetti G.M. Complement and β-amyloid neurotoxicity in vitro: a model for Alzheimer disease. Alzheimer's Res. 1:1995;29-34.
39. Olney J.W., Wozniak D.F., Farber N.B. Excitotoxic neurodegeneration in Alzheimer disease - new hypothesis and new therapeutic strategies. Arch. Neurol. 54:1997;1234-1240.
40. Osaka H., McGinty A., Hoepken U.E., Lu B., Gerard C., Pasinetti G.M. Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience. 88:1998;1073-1082.
41. Osaka H., Mukherjee P., Aisen P.S., Pasinetti G.M. Complement-derived anaphylotoxin C5a Protects against glutamate-mediated neurotoxicity. J. Cell. Biochem. 73:1999;303-311.
42. Pasinetti G.M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiology of Aging. 17:1996;707-716.
43. Pasinetti G.M. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. Neurosci. Res. 54:1998;1-6.
44. Pasinetti G.M., Tocco G., Sakhi S., Musleh W.D., DeSimoni M.G., Mascarucci P., Schreiber S., Baudry M., Finch C.E. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol. Dis. 3:1996;197-204.
45. Ray L.B., Sturgill T.W. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. 84:1987;1502-1506.
46. Reed J.C. Cytochrome c: can't live with it - can't live without it. Cell. 91:1997;559-562.
47. Rogers, J., Civin, W.H., Styren, S.D., McGeer, P.L., 1992. Immune-related mechanisms of Alzheimer's disease pathogenesis. In: Khachaturian, Z.S., Blass, J.B. (Eds.), Alzheimer's Disease: New Treatment Strategies. Marcel Dekker, Inc., New York, pp. 147-163.
48. Rother, K., Till, G.O. (Eds.), 1988. The Complement System. Springer-Verlag, Berlin.
49. Rubin J., Titus L., Nanes M.S. Regulation of complement 5a receptor expression in U937 cells by phorbol ester. J. Leuk. Biol. 50:1991;502-508.
50. Salvesen G.S., Dixit V.M. Caspases: intracellualr signaling by proteolysis. Cell. 91:1997;443-446.
51. Sola C., Tusell J.M., Serratosa J. Decreased expression of calmodulin kinase II and calcineurin messenger RNAs in the mouse hippocampus after kianic acid-induced seizures. J. Neurochem. 70:1998;1600-1608.
52. Stahel P.F., Kossman T., Morganti-Kossman M.C., Hans V.H.J., Barnum S.R. Experimental diffuse axonal injury induces enhanced neuronal C5a receptor mRNA expression in rats. Brain Res. Mol. Brain Res. 50:1997;205-212.
53. Tocco G., Musleh W., Sakhi S., Schreiber S.S., Baudry M., Pasinetti G.M. Complement and glutamate neurotoxicity: genotypic influences of C5 in a mouse model of hippocampal neurodegeneration. Mol. Chem. Neuropathol. 31:1997;289-297.
54. Velazquez P., Cribbs D.H., Poulos T.L., Tenner A.J. Aspartate residue 7 in amyloid β protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nature Medicine. 3:1997;77-79.
55. Webster S., Lue L.F., Brachova L., Tenner A.J., McGeer P.L., Terai K., Walker D.G., Bradt B., Cooper N.R., Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol. Aging. 18:1997;415-421.
56. Wetsel R.A., Kolb W.P. Expression of C5a-like biological activities by the fifth component of the human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J. Exp. Med. 157:1983;2029-2048.
57. Williams C., Schupf N., Hugli T. Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus. J. Neuroimmunol. 9:1985;29-40.
58. Wingrove J.A., DiScipio R.G., Chen Z., Potempa J., Travis J., Hugli T.E. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) Gingivalis. J. Biol. Chem. 267:1992;18902-18907.
59. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
60. Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., Vinters H.V., Frautschy S.A., Cole G. Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque associated neurons and microglia in Alzheimer's disease. Amer. J. Pathol. 152:1998;379-389.
61. Yao J., Harvath L., Gilbert D.L., Colton C.A. Chemotaxis by a CNS macrophage, the microglia. J. Neurosci. Res. 27:1990;36-42.
62. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.M. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.